Transcript
Page 1: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• This parameter is most useful for documentation of severity of asthma

(a) PEFR (b) FEV1 (c) FVC (d) FEV25

Page 2: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• This abnormaility of PEFR is NOT suggestive of asthma

• (a) diurnal variation of >20% (b) < 80% of predicted © improvement of > 20% after bronchodilator therapy (d) iurnal vaiation of <30%

Page 3: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• A child with recurrent wheezing, clubbing and malabsorption is likey to be a case of

• (a) severe bronchial asthma (b) bronchiectesis © cystic fibrosis (d) foreign body inhalation

Page 4: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• Alternative second-line therapy in combination with inhaled glucocorticoids in moderate to severe asthma in children is

• (a) salbutamol (b) theophylline © cromolyn (d) salmetrol

Page 5: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• MDIs should be used for (a) all ages (b) infants © school going children (d) teenages

Page 6: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• An asthmatic child on medication has 3 day symptoms per week and used salbutamol for it, awakes up at night coughing but has had only 2 exacerbations in the last 1 year. He is most likely

• (a) controlled (b)mildly symptomatic © uncontrolled (d) partially controlled

Page 7: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• In home treatment of acute exacerbation of asthma short acting beta 2 agonist by MDI and spacer is given, one puff very 30-60 seconds for a maximum of __ doses

(a) 2 (b) 4 © 8 (d) 10


Recommended